Document ID: chunk:federal_register_of_legislation:F2020L00502:reg:9:p2
Version: federal_register_of_legislation:F2020L00502
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 6534–8248

years before the clinical onset of malignant neoplasm of the liver; and
(b)          where smoking has ceased, the clinical onset of malignant neoplasm of the liver has occurred within 20 years of cessation;
            Note: pack-years of cigarettes, or the equivalent thereof in other tobacco products is defined in the Schedule 1 - Dictionary.
(12)      having received a cumulative equivalent dose of at least 0.5 sievert of ionising radiation to the liver at least ten years before the clinical onset of malignant neoplasm of the liver;
Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
(13)      being treated with systemic immunosuppressive therapy for solid organ, stem cell or bone marrow transplantation before the clinical onset of malignant neoplasm of the liver;
(14)      being exposed to high levels of dietary aflatoxins, on more days than not, for a period of at least ten years within the 20 years before the clinical onset of malignant neoplasm of the liver;
            Note: being exposed to high levels of dietary aflatoxins is defined in the Schedule 1 - Dictionary.
(15)      inhaling a cumulative dose of at least 2 500 ppm-years of gaseous vinyl chloride at least five years before the clinical onset of malignant neoplasm of the liver;
Note: ppm-years is defined in the Schedule 1 - Dictionary.
(16)      inhaling gaseous vinyl chloride for a cumulative period of at least 10 000 hours while working in the production or processing of vinyl chloride monomer or polyvinyl chloride, at least five years before the clinical onset of malignant neoplasm of the liver;
(17)      inability to obtain appropriate clinical management for malignant neoplasm of the liver.